Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
Takuwa
Teruhisa
T
Department of General Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawacho Nishinomiyashi Hyogo 663-8501, Japan. ttakuwa@hyo-med.ac.jp
Tanaka
Fumihiro
F
Yoneda
Kazue
K
Torii
Ikuko
I
Hashimoto
Masaki
M
Okumura
Yoshitomo
Y
Matsumoto
Seiji
S
Kondo
Nobuyuki
N
Hasegawa
Seiki
S
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D000368:Aged; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors / Q000235:genetics*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D011013:Pneumonectomy; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects; D013902:Radiography, Thoracic
D011799:Quinazolines; D004815:Epidermal Growth Factor; D000077156:Gefitinib